New nonsurgical therapies in the treatment of hepatocellular carcinoma

Christos S Georgiades, Douglas E. Ramsey, Stephen Solomon, Jean Francois H Geschwind

Research output: Contribution to journalArticle

Abstract

The last decade has seen a rapid increase in the incidence of hepatocellular carcinoma in the United States, mostly because of the increased incidence of hepatitis C. Surgical therapy remains limited to the few patients who are surgical candidates at presentation. In addition, surgery has been plagued by high recurrence rates, which can reach 80% at 3 years. Systemic chemotherapy has been found to be ineffective, with response rates approaching 10% to 20%. Nonsurgical percutaneous therapies, including percutaneous locoregional ablative procedures (ethanol or acetic acid injection, radiofrequency ablation, microwave coagulation therapy, chemotherapy infusion, laser photocoagulation, and high-intensity ultrasound) and intra-arterial procedures (radioembolization with yttrium-90 microspheres or transcatheter intra-arterial chemoembolization) are gaining popularity because they are less invasive than surgery and can be nearly as effective in prolonging survival. Multiple studies have shown good response rates with high technical success rates, as well as significant survival advantages for nonresectable disease. Furthermore, they can be performed repeatedly without compromising liver function and at a considerably lower morbidity and cost than surgery.

Original languageEnglish (US)
Pages (from-to)193-199
Number of pages7
JournalTechniques in Vascular and Interventional Radiology
Volume4
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Hepatocellular Carcinoma
Yttrium
Drug Therapy
Survival
Light Coagulation
Incidence
Hepatitis C
Microwaves
Microspheres
Acetic Acid
Lasers
Ethanol
Therapeutics
Morbidity
Costs and Cost Analysis
Recurrence
Injections
Liver

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

New nonsurgical therapies in the treatment of hepatocellular carcinoma. / Georgiades, Christos S; Ramsey, Douglas E.; Solomon, Stephen; Geschwind, Jean Francois H.

In: Techniques in Vascular and Interventional Radiology, Vol. 4, No. 3, 2001, p. 193-199.

Research output: Contribution to journalArticle

Georgiades, Christos S ; Ramsey, Douglas E. ; Solomon, Stephen ; Geschwind, Jean Francois H. / New nonsurgical therapies in the treatment of hepatocellular carcinoma. In: Techniques in Vascular and Interventional Radiology. 2001 ; Vol. 4, No. 3. pp. 193-199.
@article{7bad7612439f424ca836db02d8f36f36,
title = "New nonsurgical therapies in the treatment of hepatocellular carcinoma",
abstract = "The last decade has seen a rapid increase in the incidence of hepatocellular carcinoma in the United States, mostly because of the increased incidence of hepatitis C. Surgical therapy remains limited to the few patients who are surgical candidates at presentation. In addition, surgery has been plagued by high recurrence rates, which can reach 80{\%} at 3 years. Systemic chemotherapy has been found to be ineffective, with response rates approaching 10{\%} to 20{\%}. Nonsurgical percutaneous therapies, including percutaneous locoregional ablative procedures (ethanol or acetic acid injection, radiofrequency ablation, microwave coagulation therapy, chemotherapy infusion, laser photocoagulation, and high-intensity ultrasound) and intra-arterial procedures (radioembolization with yttrium-90 microspheres or transcatheter intra-arterial chemoembolization) are gaining popularity because they are less invasive than surgery and can be nearly as effective in prolonging survival. Multiple studies have shown good response rates with high technical success rates, as well as significant survival advantages for nonresectable disease. Furthermore, they can be performed repeatedly without compromising liver function and at a considerably lower morbidity and cost than surgery.",
author = "Georgiades, {Christos S} and Ramsey, {Douglas E.} and Stephen Solomon and Geschwind, {Jean Francois H}",
year = "2001",
doi = "10.1016/S1089-2516(01)90025-3",
language = "English (US)",
volume = "4",
pages = "193--199",
journal = "Techniques in Vascular and Interventional Radiology",
issn = "1089-2516",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - New nonsurgical therapies in the treatment of hepatocellular carcinoma

AU - Georgiades, Christos S

AU - Ramsey, Douglas E.

AU - Solomon, Stephen

AU - Geschwind, Jean Francois H

PY - 2001

Y1 - 2001

N2 - The last decade has seen a rapid increase in the incidence of hepatocellular carcinoma in the United States, mostly because of the increased incidence of hepatitis C. Surgical therapy remains limited to the few patients who are surgical candidates at presentation. In addition, surgery has been plagued by high recurrence rates, which can reach 80% at 3 years. Systemic chemotherapy has been found to be ineffective, with response rates approaching 10% to 20%. Nonsurgical percutaneous therapies, including percutaneous locoregional ablative procedures (ethanol or acetic acid injection, radiofrequency ablation, microwave coagulation therapy, chemotherapy infusion, laser photocoagulation, and high-intensity ultrasound) and intra-arterial procedures (radioembolization with yttrium-90 microspheres or transcatheter intra-arterial chemoembolization) are gaining popularity because they are less invasive than surgery and can be nearly as effective in prolonging survival. Multiple studies have shown good response rates with high technical success rates, as well as significant survival advantages for nonresectable disease. Furthermore, they can be performed repeatedly without compromising liver function and at a considerably lower morbidity and cost than surgery.

AB - The last decade has seen a rapid increase in the incidence of hepatocellular carcinoma in the United States, mostly because of the increased incidence of hepatitis C. Surgical therapy remains limited to the few patients who are surgical candidates at presentation. In addition, surgery has been plagued by high recurrence rates, which can reach 80% at 3 years. Systemic chemotherapy has been found to be ineffective, with response rates approaching 10% to 20%. Nonsurgical percutaneous therapies, including percutaneous locoregional ablative procedures (ethanol or acetic acid injection, radiofrequency ablation, microwave coagulation therapy, chemotherapy infusion, laser photocoagulation, and high-intensity ultrasound) and intra-arterial procedures (radioembolization with yttrium-90 microspheres or transcatheter intra-arterial chemoembolization) are gaining popularity because they are less invasive than surgery and can be nearly as effective in prolonging survival. Multiple studies have shown good response rates with high technical success rates, as well as significant survival advantages for nonresectable disease. Furthermore, they can be performed repeatedly without compromising liver function and at a considerably lower morbidity and cost than surgery.

UR - http://www.scopus.com/inward/record.url?scp=0034767445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034767445&partnerID=8YFLogxK

U2 - 10.1016/S1089-2516(01)90025-3

DO - 10.1016/S1089-2516(01)90025-3

M3 - Article

C2 - 11748557

AN - SCOPUS:0034767445

VL - 4

SP - 193

EP - 199

JO - Techniques in Vascular and Interventional Radiology

JF - Techniques in Vascular and Interventional Radiology

SN - 1089-2516

IS - 3

ER -